An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Κύριος συγγραφέας: | Bristy, Israt Zerin |
---|---|
Άλλοι συγγραφείς: | Kabir, Md. Tanvir |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2021
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/15619 |
Παρόμοια τεκμήρια
-
Molecules associated with the development of lung cancer
ανά: Rahman, Adree, κ.ά.
Έκδοση: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
ανά: Shabnam, Musharrat
Έκδοση: (2018) -
Immunotherapy in the Management of Lung Cancer
ανά: Tasnim, Humayra
Έκδοση: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
ανά: Paul, Pulock
Έκδοση: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
ανά: Mim, Shanzida
Έκδοση: (2023)